Suppr超能文献

首例脊柱转移性造釉细胞瘤:病例报告及文献复习。

First Confirmed Metastatic Adamantinoma of the Spine: Case Report and Literature Review.

机构信息

Spine Unit, Orthopaedic and Trauma Service, Hospital Español de Mendoza, Mendoza, Argentina.

Department of Oncologic and Degenerative Spine Surgery, Istituto Ortopedico Rizzoli, Bologna, Italy.

出版信息

Global Spine J. 2015 Aug;5(4):e7-e12. doi: 10.1055/s-0034-1394362. Epub 2014 Oct 25.

Abstract

Study Design Case report and literature review. Objective To present the first case of metastatic adamantinoma of the spine with immunohistochemical confirmation and an updated literature review. Summary of Background Data Spinal metastatic disease could be difficult to diagnose because of the multiple differential diagnoses involved. Spinal surgeons must be aware of unusual primary extra-axial tumors that metastasize to the spine because in certain cases the primary surgery must determine the prognosis of this lesion. Methods We present a fully documented case of a middle-aged man with tibial adamantinoma who developed spine metastasis, confirmed by immunohistochemistry. A literature review was done. Results Based on clinical, imaging, and pathology findings, we provide evidence for the first proven metastatic adamantinoma of the spine, adding this condition to the long list of differential diagnoses of secondary spinal disease. Conclusions Adamantinoma is a very rare bone tumor representing ∼1% of primary bone tumors. Spinal metastatic adamantinoma with immunohistochemical confirmation has not been described previously. Due to the lack of specific image findings or serum markers and multiple differential diagnoses, biopsy with immunohistochemical confirmation is mandatory, because "en block resection" might prove to be curative treatment.

摘要

研究设计

病例报告和文献复习。目的:介绍首例经免疫组织化学证实的脊柱造釉细胞瘤转移病例,并进行文献复习。背景数据总结:由于涉及多种鉴别诊断,脊柱转移疾病的诊断可能具有挑战性。脊柱外科医生必须意识到罕见的原发于轴外组织、转移至脊柱的肿瘤,因为在某些情况下,原发手术必须决定该病变的预后。方法:我们报告了一例中年胫骨造釉细胞瘤患者发生脊柱转移的完整病例,该病例经免疫组织化学证实。我们进行了文献复习。结果:根据临床、影像学和病理学发现,我们提供了首例经证实的脊柱转移造釉细胞瘤的证据,将该疾病添加到继发脊柱疾病的大量鉴别诊断中。结论:造釉细胞瘤是一种非常罕见的骨肿瘤,占原发性骨肿瘤的 1%左右。经免疫组织化学证实的脊柱转移造釉细胞瘤以前尚未描述过。由于缺乏特定的影像学发现或血清标志物以及多种鉴别诊断,因此必须进行免疫组织化学证实的活检,因为“整块切除”可能被证明是一种有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2695/4516730/5036994867c5/10-1055-s-0034-1394362-i1400076-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验